Related Experiment Videos
Primary cytotoxic T lymphocyte induction using peptide-stripped autologous cells
P Langlade-Demoyen1, J P Levraud, P Kourilsky
1INSERM U277, Département d'Immunologie, Institut Pasteur, Paris, France.
International Immunology
|November 1, 1994
Summary
Mild acid treatment can detach peptides from cell surface MHC class I molecules. This peptide-stripped MHC class I can be reloaded with new peptides, enabling effective cancer immunotherapy and T cell responses.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- MHC class I molecules present endogenous peptides.
- MHC class I-peptide complexes are sensitive to pH changes.
- Current methods for manipulating MHC class I peptide loading are limited.
Purpose of the Study:
- To investigate the effect of mild acid treatment on cell surface MHC class I-peptide complexes.
- To determine if peptide-stripped MHC class I can be reloaded with exogenous peptides for immunotherapy.
- To explore the potential of this method for inducing peptide-specific cytotoxic T lymphocyte (CTL) responses.
Main Methods:
- Mild acid treatment of cells to dissociate MHC class I-peptide complexes.
- Peptide-reloading of MHC class I molecules with exogenous peptides.
- In vitro mixed lymphocyte cultures to assess CTL induction.
- In vivo immunization and tumor challenge experiments in mice.
Main Results:
- Brief, mild acid treatment effectively stripped peptides from cell surface MHC class I without affecting cell viability.
- Peptide-stripped MHC class I molecules retained their capacity to bind exogenous peptides.
- Peptide-reloaded blasts induced peptide-specific primary CTL responses in vitro.
- Mice immunized with peptide-reloaded blasts showed protection against tumor challenge.
Conclusions:
- Mild acid treatment offers a novel method for peptide-stripping and re-loading of MHC class I molecules.
- This approach holds significant potential for viral and tumor immunotherapy.
- The findings provide insights into the mechanisms of primary CTL induction.